MLICM
CTXR icon

Metropolitan Life Insurance Company (MetLife)’s Citius Pharmaceuticals CTXR Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-289
Closed -$8.67K – 2409
2023
Q2 		$8.67K Buy
+289
New +$9.51K ﹤0.01% 2377
2021
Q3 		– Sell
-1,566
Closed -$136K – 2844
2021
Q2 		$136K Buy
+1,566
New +$94.1K ﹤0.01% 2419

Other funds holding CTXR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CTXR Position: Q3 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Citius Pharmaceuticals (CTXR) in Q3 2023, closing a stake of 289 shares — an estimated $8.67K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CTXR in Q2 2021 and held it in 2 quarters. The position peaked at $136K in Q2 2021. 74 funds tracked by Wall St. Rank hold CTXR as of Q3 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Citius Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 289 Citius Pharmaceuticals shares in Q3 2023, an estimated $8.67K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Citius Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Citius Pharmaceuticals position peaked at $136K in Q2 2021.
  • 74 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q3 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.